As of 2025-08-23, the Relative Valuation of Gemini Therapeutics Inc (GMTX) is (15.40) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.35 USD, the upside of Gemini Therapeutics Inc based on Relative Valuation is -1240.8%.
The range of the Relative Valuation is (15.02) - (19.60) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.9x - 18.1x | 14.3x |
| Forward P/E multiples | 13.2x - 21.2x | 14.2x |
| Fair Price | (15.02) - (19.60) | (15.40) |
| Upside | -1212.8% - -1552.2% | -1240.8% |
| Date | P/E |